(Economic Observer) A-share semi-annual report: more than 80% of the company’s total profit revenue exceeds 23.5 trillion yuan
China News Service, Beijing, September 1 (Reporter Xia Bin) The disclosure of the 2020 A-share listed company's semi-annual report has settled.
As of September 1st, with the exception of Baofeng Group and Qianshantuit unable to disclose within the statutory period, 3,975 listed companies in Shanghai and Shenzhen have disclosed their 2020 semi-annual financial reports. Over 80% of the companies achieved profitability in the first half of the year and their overall performance in the second quarter. There is also a significant improvement.
Specifically, in the first half of the year, all A-share companies achieved a total operating income of 23,518,598 million yuan (RMB, the same below), of which the second quarter revenue was 12,825,174 million yuan, an increase of 20.11% from the previous quarter; the total net profit attributable to shareholders of the parent company was 1,845,352 million yuan. Among them, the net profit in the second quarter was 101.918 billion yuan, an increase of 22.77% from the previous quarter.
The new crown pneumonia epidemic that broke out at the beginning of the year brought a greater impact on the performance of listed companies, but from the data, it can be seen that the performance of the second quarter has improved significantly compared with the first quarter.
For example, the operating income growth rate of listed companies in the first quarter hit a record low of -7.74%, and it recovered strongly in the second quarter, rebounding to 4.15%.
Li Zhan, chief economist of Zhongshan Securities, believes that from the perspective of the interim report, the number of profitable listed companies has improved significantly compared with the first quarter, and only 70% of them achieved profitability in the first quarter.
However, he also emphasized that if it is subdivided into various industries, it can be seen that there is a trend of differentiation. Some industries are more severely affected by the epidemic and their performance still needs to be improved. However, there are also many industries that have gradually returned to normal in the terminal market and supply side. Performance has been significantly improved.
The data shows that the revenue and net profit of the Sci-tech Innovation Board have increased significantly, the growth rate of the ChiNext Board has been large, the performance of the small and medium-sized enterprises has been stable, and the performance of the main board has been poor; from the performance of various industries, finance, construction, fossil energy, and transportation equipment Transportation and transportation are still big revenue players, with total industry revenue exceeding 1 trillion yuan.
In terms of net profit attributable to the parent company, the financial and energy listed companies of all A-shares are more on the list, of which Industrial and Commercial Bank of China ranked first with a score of 148.79 billion yuan, and China Construction Bank, Agricultural Bank of China and Bank of China ranked second to fourth. , The four banks made more than 100 billion yuan in the first half of the year.
The top three with the highest income are Sinopec’s 1,034.246 billion yuan, PetroChina’s 929.45 billion yuan, and China Construction’s 728.188 billion yuan. The top three with the most losses are PetroChina’s net profit of -29.986 billion yuan and West China. Water shares of -27.09 billion yuan and Sinopec's -22.882 billion yuan.
If compared with the growth rate, Shengxiang Bio is the most amazing company in the first half of the year.
The data shows that in the first half of the year, Shengxiang Biological's operating income increased by 1159.39% year-on-year, and its net profit increased by 14687.2% year-on-year, both of which ranked first.
This company, whose main business is in vitro testing, relied on new coronavirus testing products for its growth in the first half of the year.
Shengxiang Biotech stated that the market demand for new coronavirus nucleic acid detection reagents and other related products has increased significantly in the short term, leading to a significant increase in the company's performance this year.
In addition, the semi-annual report can also observe the outstanding performance of science and technology enterprises.
The data shows that in the first half of the year, the net profit of companies on the Sci-tech Innovation Board, ChiNext Board and SME Board increased by 42.29%, 13.97% and 8.53% respectively.
Among them, 60% of the performance of the Supermarket of the Science and Technology Innovation Board has achieved growth.
Judging from the R&D investment indicators in the semi-annual report, A-share listed companies are paying more and more attention to the "hard power" related to long-term development. More than 1920 companies have increased R&D expenses year-on-year, which means that nearly half of the A-share companies are increasing R&D. Among them, there are at least 1,448 companies with an increase of more than 10%.
Yin Yue, chief market analyst at Yuekai Securities, believes that the performance of the 2019 annual report shows that technology stocks have shown a relatively good momentum of development. Under the influence of public health incidents, corporate profits in the first quarter of this year have bottomed out again and the inventory cycle has been pulled. Long, with the continuous recovery of the domestic economy in the second quarter, technology stocks have become highly resilient.
Yin Yue said bluntly: "At present, China's economy is still in the process of recovery, and the profits of companies that are limited by the epidemic will continue to be repaired." (End)